Home Cart Sign in  
Chemical Structure| 85416-73-5 Chemical Structure| 85416-73-5

Structure of (S)-(+)-Rolipram
CAS No.: 85416-73-5

Chemical Structure| 85416-73-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(S)-(+)-Rolipram is a PDE4-inhibitor and an anti-inflammatory agent, less potent than its R-enantiomer.

Synonyms: S-(+)-Rolipram; (+)-Rolipram; (S)-Rolipram

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (S)-(+)-Rolipram

CAS No. :85416-73-5
Formula : C16H21NO3
M.W : 275.34
SMILES Code : O=C1NC[C@@H](C1)C2=CC=C(C(OC3CCCC3)=C2)OC
Synonyms :
S-(+)-Rolipram; (+)-Rolipram; (S)-Rolipram
MDL No. :MFCD03093861
InChI Key :HJORMJIFDVBMOB-GFCCVEGCSA-N
Pubchem ID :158758

Safety of (S)-(+)-Rolipram

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
(S)-(+)-Rolipram, known as (+)-Rolipram, is a selective inhibitor of cyclic AMP (cAMP)-specific phosphodiesterase 4 (PDE4) with an IC50 of 1100 nM. It is effective in suppressing tumor necrosis factor-alpha (TNFα) production in human mononuclear cells[1].[2].[3].
Target
  • PDE4

    PDE4, IC50:0.75 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse primordial germ cell-like cells (PGCLCs) 10 μM 7 days Screening for chemicals that promote PGCLC proliferation, (S)-(+)-Rolipram was found to significantly promote PGCLC proliferation EMBO J. 2017 Jul 3;36(13):1888-1907
hippocampal slices 0.1µM 60 min To investigate the rescuing effect of rolipram on LTP deficits caused by sleep deprivation, results showed that rolipram rescued the LTP deficits caused by sleep deprivation Nature. 2009 Oct 22;461(7267):1122-5
Adult feline left ventricular myocytes 1 μM To evaluate the effect of rolipram on ISO-mediated cAMP generation, results showed that rolipram significantly enhanced ISO-induced cAMP generation. Circulation. 2014 Nov 11;130(20):1800-11
hippocampal slices 1 μM 20 min To test the effect of rolipram on LTP deficits in hippocampal slices from APP/PS1 mice. Results showed that rolipram significantly ameliorated LTP deficits in APP/PS1 hippocampal slices, bringing LTP levels close to those of wild-type mice. J Clin Invest. 2004 Dec;114(11):1624-34
CHO cells 0.1, 0.25, 0.5, 1.0, and 2.0 μM 18 h Rolipram overcame inhibition by MAG and myelin in a dose-dependent manner, completely blocking inhibition by MAG at 0.5 μM. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8786-90.
hippocampal slices 0.03 μM, 0.3 μM, 3.0 μM 45 min Low concentrations of rolipram had no significant effect on basal cAMP levels, but significantly amplified the cAMP response to forskolin stimulation. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Sleep deprivation model Intraperitoneal injection 1 mg/kg Injected immediately and 2.5 hours after training To investigate the rescuing effect of rolipram on memory deficits caused by sleep deprivation, results showed that rolipram rescued the memory deficits caused by sleep deprivation Nature. 2009 Oct 22;461(7267):1122-5
Mice APP/PS1 double-transgenic mice Subcutaneous injection 0.03 mg/kg Acute administration: single dose 30 minutes before testing; Long-term administration: daily dose of 0.03 mg/kg for 3 weeks, followed by 6-8 weeks of withdrawal before testing. To test the acute and long-term effects of rolipram on cognitive and synaptic functions in APP/PS1 mice. Acute administration significantly improved contextual fear conditioning deficits in APP/PS1 mice but had no significant effect on spatial working memory. Long-term administration significantly improved synaptic function (BST and LTP) and multiple cognitive functions (including associative learning, working memory, and reference memory) in APP/PS1 mice, with effects lasting at least 2 months after treatment cessation. J Clin Invest. 2004 Dec;114(11):1624-34
Mice C57/Bl6 mice Subcutaneous injection 0.1 μmol/kg, 3.0 μmol/kg 30 min before training Low-dose rolipram significantly enhanced long-term memory (24-hr freezing), while high doses caused behavioral toxicity. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5
Sprague-Dawley rats Acute and subacute inflammation models Intraperitoneal injection 8 mg/kg Single dose, observed for 60 min or 4 h Rolipram significantly inhibited PAF or LPS-induced leukocyte rolling, adhesion, and emigration, and downregulated P- and E-selectin expression, but had no effect on ICAM-1 and VCAM-1 expression. Br J Pharmacol. 2002 Apr;135(8):1872-81

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.63mL

0.73mL

0.36mL

18.16mL

3.63mL

1.82mL

36.32mL

7.26mL

3.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories